Blood clots entered her lungs the day a Jennifer Hardy Jun 25 min read Medicare GLP-1 Bridge Program: What It Is, Who Qualifies, and How It Works If youre a Medicare beneficiary interested in weight-loss medications like Wegovy, Zepbound, or Foundayo, the Medicare GLP-1 Bridge could be a game-changer
Malhotra S, Sawhney G, Pandhi P
And the honest truth is that the emerging science a 2026 systematic review, a growing body of pharmacovigilance data, and the lived experience of thousands of people is confirming something that anyone who has lived through food dysfunction already knows: You cannot shortcut the reward system without consequences to the full emotional landscape
Implications for clinical practice: If you manage T2D patients, now is the time to ask: Have I considered liver health in this patient? Have I screened for advanced fibrosis? Is my choice of glucose-lowering therapy optimised for both glycaemic and hepatic benefit? Even in settings where hepatology referrals are limited, simple non-invasive tests (e.g., FIB-4) may help stratify risk
Tirzepatide hits both GLP-1 and GIP receptors simultaneously
Every patient responds differently, and those differences only become apparent when physiology is measured rather than inferred from weight change weeks or months later
